BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12102601)

  • 1. The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
    Berg RW; Ferguso PJ; DeMoor JM; Vincen MD; Koropatnick J
    Curr Drug Targets; 2002 Aug; 3(4):297-309. PubMed ID: 12102601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.
    Jason TL; Berg RW; Vincent MD; Koropatnick J
    Gene Expr; 2007; 13(4-5):227-39. PubMed ID: 17605297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance.
    Berg RW; Ferguson PJ; Vincent MD; Koropatnick DJ
    Cancer Gene Ther; 2003 Apr; 10(4):278-86. PubMed ID: 12679800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells.
    Ferguson PJ; Collins O; Dean NM; DeMoor J; Li CS; Vincent MD; Koropatnick J
    Br J Pharmacol; 1999 Aug; 127(8):1777-86. PubMed ID: 10482907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.
    Ferguson PJ; DeMoor JM; Vincent MD; Koropatnick J
    Br J Pharmacol; 2001 Dec; 134(7):1437-46. PubMed ID: 11724749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase.
    Berg RW; Werner M; Ferguson PJ; Postenka C; Vincent M; Koropatnick DJ; Behrend E
    J Pharmacol Exp Ther; 2001 Aug; 298(2):477-84. PubMed ID: 11454908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.
    Jason TL; Figueredo R; Ferguson PJ; Vincent MD; Berg RW; Koropatnick J
    DNA Cell Biol; 2008 May; 27(5):229-40. PubMed ID: 18358073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase: a critical target in cancer therapy?
    Rustum YM
    Front Biosci; 2004 Sep; 9():2467-73. PubMed ID: 15353299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
    DeMoor JM; Vincent MD; Collins OM; Koropatnick J
    Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of antisense oligodeoxynucleotides to down-regulate thymidylate synthase in mesothelioma.
    Flynn J; Berg RW; Wong T; van Aken M; Vincent MD; Fukushima M; Koropatnick J
    Mol Cancer Ther; 2006 Jun; 5(6):1423-33. PubMed ID: 16818500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed.
    Di Cresce C; Figueredo R; Ferguson PJ; Vincent MD; Koropatnick J
    J Pharmacol Exp Ther; 2011 Sep; 338(3):952-63. PubMed ID: 21673071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.
    Longley DB; Ferguson PR; Boyer J; Latif T; Lynch M; Maxwell P; Harkin DP; Johnston PG
    Clin Cancer Res; 2001 Nov; 7(11):3533-9. PubMed ID: 11705873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
    Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA.
    Abe S; Kubota T; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Jpn J Cancer Res; 2000 Nov; 91(11):1192-8. PubMed ID: 11092986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and other solid tumours.
    Jackman AL; Melin CJ; Kimbell R; Brunton L; Aherne GW; Theti DS; Walton M
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):215-23. PubMed ID: 12084463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell lines.
    Pandyra AA; Berg R; Vincent M; Koropatnick J
    J Pharmacol Exp Ther; 2007 Jul; 322(1):123-32. PubMed ID: 17452420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
    Peters GJ; Backus HH; Freemantle S; van Triest B; Codacci-Pisanelli G; van der Wilt CL; Smid K; Lunec J; Calvert AH; Marsh S; McLeod HL; Bloemena E; Meijer S; Jansen G; van Groeningen CJ; Pinedo HM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):194-205. PubMed ID: 12084461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of thymidylate synthase modulators by a novel screening assay.
    Wu Q; Dolnick BJ
    Mol Pharmacol; 2003 Jan; 63(1):167-73. PubMed ID: 12488549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed.
    Peters GJ; van Triest B; Backus HH; Kuiper CM; van der Wilt CL; Pinedo HM
    Eur J Cancer; 2000 May; 36(7):916-24. PubMed ID: 10785598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.